TY - JOUR
T1 - A protein quality control pathway regulated by linear ubiquitination
AU - van Well, Eva M.
AU - Bader, Verian
AU - Patra, Maria
AU - Sánchez-Vicente, Ana
AU - Meschede, Jens
AU - Furthmann, Nikolas
AU - Schnack, Cathrin
AU - Blusch, Alina
AU - Longworth, Joseph
AU - Petrasch-Parwez, Elisabeth
AU - Mori, Kohji
AU - Arzberger, Thomas
AU - Trümbach, Dietrich
AU - Angersbach, Lena
AU - Showkat, Cathrin
AU - Sehr, Dominik A.
AU - Berlemann, Lena A.
AU - Goldmann, Petra
AU - Clement, Albrecht M.
AU - Behl, Christian
AU - Woerner, Andreas C.
AU - Saft, Carsten
AU - Wurst, Wolfgang
AU - Haass, Christian
AU - Ellrichmann, Gisa
AU - Gold, Ralf
AU - Dittmar, Gunnar
AU - Hipp, Mark S.
AU - Hartl, F. Ulrich
AU - Tatzelt, Jörg
AU - Winklhofer, Konstanze F.
N1 - Funding Information:
We thank Drs. A. Voigt for Htt-polyQ plasmids, H. Meyer for the p97/VCP plasmid, N. Mizushima for ATG5 KO MEFs, L. Lanier for providing videos of striatal neuron preparation, and Genentech for providing the 1F11/3F5/Y102L antibody. We wish to thank the patients and their families for brain samples. The research leading to these results has received funding from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) (TA 167/6-1, WI 2111/4-1, WU 164/5-1, SFB1177 to C.B.), the Munich Cluster for Systems Neurology (C.H., F.U.H., K.F.W., M.S.H., W.W.), Germany’s Excellence Strategy— EXC-2033—Projektnummer 390677874 (J.T., K.F.W.), the Hans and Ilse Breuer Foundation (M.P.), the German Federal Ministry of Education and Research through the Integrated Network MitoPD and HIT-Tau (grants 031A430E and 01EK1605C to W.W.), and the Medical Faculty of the Ruhr University Bochum (FoRUM F832R-2014 to K.F.W.). SR-SIM microscopy was funded by the German Research Foundation and the State Government of North Rhine-Westphalia (INST 213/840-1 FUGG).
Publisher Copyright:
© 2019 The Authors
PY - 2019/5/2
Y1 - 2019/5/2
N2 - Neurodegenerative diseases are characterized by the accumulation of misfolded proteins in the brain. Insights into protein quality control mechanisms to prevent neuronal dysfunction and cell death are crucial in developing causal therapies. Here, we report that various disease-associated protein aggregates are modified by the linear ubiquitin chain assembly complex (LUBAC). HOIP, the catalytic component of LUBAC, is recruited to misfolded Huntingtin in a p97/VCP-dependent manner, resulting in the assembly of linear polyubiquitin. As a consequence, the interactive surface of misfolded Huntingtin species is shielded from unwanted interactions, for example with the low complexity sequence domain-containing transcription factor Sp1, and proteasomal degradation of misfolded Huntingtin is facilitated. Notably, all three core LUBAC components are transcriptionally regulated by Sp1, linking defective LUBAC expression to Huntington's disease. In support of a protective activity of linear ubiquitination, silencing of OTULIN, a deubiquitinase with unique specificity for linear polyubiquitin, decreases proteotoxicity, whereas silencing of HOIP has the opposite effect. These findings identify linear ubiquitination as a protein quality control mechanism and hence a novel target for disease-modifying strategies in proteinopathies.
AB - Neurodegenerative diseases are characterized by the accumulation of misfolded proteins in the brain. Insights into protein quality control mechanisms to prevent neuronal dysfunction and cell death are crucial in developing causal therapies. Here, we report that various disease-associated protein aggregates are modified by the linear ubiquitin chain assembly complex (LUBAC). HOIP, the catalytic component of LUBAC, is recruited to misfolded Huntingtin in a p97/VCP-dependent manner, resulting in the assembly of linear polyubiquitin. As a consequence, the interactive surface of misfolded Huntingtin species is shielded from unwanted interactions, for example with the low complexity sequence domain-containing transcription factor Sp1, and proteasomal degradation of misfolded Huntingtin is facilitated. Notably, all three core LUBAC components are transcriptionally regulated by Sp1, linking defective LUBAC expression to Huntington's disease. In support of a protective activity of linear ubiquitination, silencing of OTULIN, a deubiquitinase with unique specificity for linear polyubiquitin, decreases proteotoxicity, whereas silencing of HOIP has the opposite effect. These findings identify linear ubiquitination as a protein quality control mechanism and hence a novel target for disease-modifying strategies in proteinopathies.
KW - Huntingtin
KW - LUBAC
KW - OTULIN
KW - p97
KW - protein aggregation
UR - http://www.scopus.com/inward/record.url?scp=85064560687&partnerID=8YFLogxK
U2 - 10.15252/embj.2018100730
DO - 10.15252/embj.2018100730
M3 - Article
C2 - 30886048
AN - SCOPUS:85064560687
SN - 0261-4189
VL - 38
JO - EMBO Journal
JF - EMBO Journal
IS - 9
M1 - e100730
ER -